Matthew Shea
Stock Analyst at Needham
(3.33)
# 2,449
Out of 4,966 analysts
42
Total ratings
53.6%
Success rate
9.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Reiterated: Buy | $41 | $37.98 | +7.95% | 4 | Aug 7, 2026 | |
| STLN Starling Oncology | Reiterated: Buy | $7 | $6.17 | +13.45% | 10 | Aug 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $89.45 | - | 9 | Aug 6, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $4.15 | +20.63% | 12 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $20.33 | +47.57% | 7 | May 7, 2026 |
Astrana Health
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $37.98
Upside: +7.95%
Starling Oncology
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $6.17
Upside: +13.45%
agilon health
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $89.45
Upside: -
Evolent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $4.15
Upside: +20.63%
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $20.33
Upside: +47.57%